ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
05/26/201611:00:00Mylan to Present at Goldman Sachs 37th Annual Global Healthcare...
05/25/201617:24:02Statement of Changes in Beneficial Ownership (4)
05/25/201617:22:43Statement of Changes in Beneficial Ownership (4)
05/25/201617:05:02Proxy Statement (definitive) (def 14a)
05/23/201607:30:00Mylan Launches First Generic Doryx® Delayed-Release Tablets...
05/18/201606:04:39Filing of Certain Prospectuses and Communications in Connection...
05/17/201617:45:00Mylan Updates Timetable for Commencement of Acceptance Period...
05/17/201617:45:00Mylan Updates Timetable for Commencement of Acceptance Period...
05/16/201618:50:57Filing of Certain Prospectuses and Communications in Connection...
05/16/201610:06:06Statement of Changes in Beneficial Ownership (4)
05/13/201617:41:48Registration Statement for Securities to Be Issued in Business...
05/13/201609:00:00Mylan to Acquire Renaissance's Leading Topicals-Focused Specialty...
05/12/201607:30:00Mylan Launches Generic Frova® Tablets
05/10/201618:00:23Filing of Certain Prospectuses and Communications in Connection...
05/10/201617:59:58Filing of Certain Prospectuses and Communications in Connection...
05/09/201619:01:39Statement of Changes in Beneficial Ownership (4)
05/09/201618:11:12Filing of Certain Prospectuses and Communications in Connection...
05/05/201617:39:21Proxy Statement - Notice of Shareholders Meeting (preliminary...
05/05/201607:30:00Mylan Launches Generic Apresoline® Injection
05/04/201608:01:00Sarah Jessica Parker Shares Her Personal Experience with Potentially...

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad